$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
028-123456789
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Medical Q&A
Medical Q&A
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Healthcare products
Healthcare products
About Us
About Us
Home
Oncology
Oncology
Is the new lung cancer drug Pozitinib available in China?
2025-10-19 11:44:20
Check Details
The emergence of platinib ushered in a new era of RET targets
2025-10-19 11:44:20
Check Details
How many days will it take for patients with lung cancer to feel the effects of pocitinib?
2025-10-19 11:44:20
Check Details
Has the oral MET inhibitor tepotinib been approved for marketing in China?
2025-10-19 11:44:20
Check Details
Safety and effectiveness of platinib in the treatment of RET fusion-positive metastatic non-small cell lung cancer
2025-10-19 11:44:20
Check Details
Is tepotinib included in China’s national medical insurance?
2025-10-19 11:44:20
Check Details
Bochitinib is a new oral cancer cell inhibitor_Cornhule
2025-10-19 11:44:20
Check Details
Where is the RET inhibitor platinib available? How much does it cost?
2025-10-19 11:44:20
Check Details
Which country does the new lung cancer drug Pozitinib come from?
2025-10-19 11:44:20
Check Details
Where can I buy the lung cancer drug Pozitinib?
2025-10-19 11:44:20
Check Details
Is icotinib an adjuvant drug after lung cancer surgery?
2025-10-19 11:44:20
Check Details
How long do patients with lung cancer need to take icotinib for treatment?
2025-10-19 11:44:20
Check Details
1
2
...
3866
3867
3868
3869
3870
3871
3872
...
4149
4150
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Pralsetinib: The RET Precision-Targeted Therapy That Rewrites the Treatment History of Rare Cancers
2
Detailed introduction to the instruction manual of revumenib
3
Ryeqo (Relugolix compound tablets) - long-term treatment for uterine fibroids
4
How effective is Ryeqo (Relugolix compound tablets)?
5
U.S. FDA approves Ryeqo to treat menorrhagia related to uterine fibroids in premenopausal women!
6
How much does Ryeqo cost? Where can I buy it in Liaoning?
7
Ryeqo - a good medicine that can effectively improve menorrhagia and pain caused by uterine fibroids
8
How much does Ryeqo cost? Is it available in Shandong now?
9
Comprehensive summary-the advantages, disadvantages and indications of different preparations of estradiol
10
What is the therapeutic effect of myfembree
11
What are the serious side effects of myfembree and how to deal with them?
12
How effective is Ryeqo in treating uterine fibroids?